AGEN

Agenus Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$6.87

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %17.1 / %30

Non-compliant assets / Total market cap %43.1 / %30

Non-compliant revenue / Total income %0.6 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.

Website

Analysis (Turkish): AGEN Hissesi Caiz mi, Helal mi? Agenus Inc. Katılım Analizi